The Methodist Hospital Research Institute
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, The Methodist Hospital Research Institute sits in the top decile of US sponsors by registered trial count (#214 of 15,742 sponsors by registered trial count).
The Methodist Hospital Research Institute: 126 sponsored US clinical trials, 49 recruiting.
The Methodist Hospital Research Institute sponsors 126 registered US clinical trials on ClinicalTrials.gov, 49 of them currently recruiting, and 48 completed. 12 of these trials are in Phase 3-4 (later-stage) and 65 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Urge Incontinence, with 2 trials.
Top-decile sponsor footprint
The Methodist Hospital Research Institute ranks in the top decile of sponsors by registered trial count (#214 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
48 of 64 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
126 total, page 3 of 3
Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder
NCT03033355
Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel
NCT02073487
A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy
NCT02111824
Olive Oil for High Risk Breast Cancer Prevention in Women
NCT02068092
Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation
NCT01898221
Ciprofloxacin for Prevention of BK Infection
NCT01789203
The Use of CoSeal (Sealant Agent) in Patients During Left Ventricular Assist Device Surgery
NCT01605019
Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT)
NCT01446016
A Trial of Esophageal and Gastric Stenting for Leak or Perforation
NCT01107249
Safety of Riluzole in Patients With Acute Spinal Cord Injury
NCT00876889
Neo-Adjuvant Study in Triple Negative Breast Cancer Patients
NCT01097642
Hyperlipidemia and Statin Therapy in Amyotrophic Lateral Sclerosis
NCT01592084
Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer
NCT00521274
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer
NCT00521781
Adrenal Insufficiency in Septic Shock
NCT00842933
Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC
NCT00522249
Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy
NCT00448097
Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer
NCT00448149
Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer
NCT00450008
Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer
NCT00440973
Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer
NCT00447473
Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer
NCT00445523
Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer
NCT00448409
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
NCT00445042
Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer
NCT00446368
Efficacy and Safety Study of Xyotax to Treat Prostate Cancer
NCT00446836
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 30 |
| Phase 2 | 35 |
| Phase 3 | 2 |
| Phase 4 | 10 |
What is open in the The Methodist Hospital Research Institute pipeline
49 recruiting of 126 indexed (39% open); 48 completed (38%).
Phase mix: 12 late (III/IV) vs 65 early (I/II) (early-phase heavy).
Top condition: Urge Incontinence (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The Methodist Hospital Research Institute: open-pipeline peers nationwide
Peers matched on 126 registered trials and 39% open enrollment, not the therapeutic-area sidebar.
The Methodist Hospital Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 126 trials (± recruiting share)
- Stony Brook University · 127 trials · 19% recruiting
- Methodist Health System · 125 trials · 29% recruiting
- Jazz Pharmaceuticals · 128 trials · 12% recruiting
- University of Illinois at Urbana-Champaign · 129 trials · 14% recruiting
Sponsors near 39% open enrollment (± trial volume)
- argenx · 39% recruiting · 49 trials
- Morehouse School of Medicine · 38% recruiting · 13 trials
- Northeastern University · 38% recruiting · 39 trials
- Thomas Hope · 38% recruiting · 13 trials
Related
What to do with this The Methodist Hospital Research Institute page
126 registered trials is a research-attention snapshot, not an endorsement of The Methodist Hospital Research Institute or any single study.
- 49 of The Methodist Hospital Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Urge Incontinence is the condition The Methodist Hospital Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Urge Incontinence trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
The Methodist Hospital Research Institute pipeline card: 126 registered trials from official public datasets.Report a data error.